We are proud to be newly ranked in the Legal 500 Life sciences and healthcare category, entering at Tier 4, while once again securing Tier 1 rankings in both the PATMA: Patent attorney and PATMA: Trade mark attorney categories in Legal 500 2027.
 |
|
| PATMA: Patent attorney & trade mark attorney | Life sciences and healthcare |
Comments include:
“The practice at Mewburn Ellis LLP is well-placed to assist SMEs, start-ups, research institutions, and pharma and medical device companies with a breadth of complex patent prosecution cases.”
“Mewburn Ellis LLP handles a range of IP matters spanning transactional support and contentious work in the life sciences and healthcare industry.”
“Mewburn Ellis LLP has well-established capabilities in assisting its sector-spanning clientele with a range of complex advisory, opposition, prosecution, and dispute matters, including advising on portfolio management, filing strategy, and handling litigation.”
We are also delighted to see the following individuals recognised:
Leading Partners: Graeme Moore
Next Generation Partners: Emma Graham, Rebecca Anderson-Smith
Leading Associates: Jonathan Garner
Other Key Individuals: Adam Gregory, Andrew Pitts, Andrew Williams, Andy King, Camilla Balleny, Camille Terfve, Chloe Flower, Chris Denison, Claire Evans, Jacqueline Pang, Jan Rether, Jeremy Webster, Joe McAlary, Jonathan Wills, Paul Dunne, Robert Watson, Sabrina Rak, Sean Jauss, Simon Kiddle.
Congratulations to everyone that has been recognised this year and thanks to all our clients and referees for providing such wonderful feedback.
Read our full Legal 500 review.
About Legal 500
Legal 500 is a leading global legal directory that ranks law firms and lawyers based on extensive independent research, including client feedback, peer reviews, and firm submissions. Its coverage spans over 100 jurisdictions and a broad range of practice areas, making it one of the most comprehensive and trusted resources for assessing legal expertise and market presence worldwide.
.png)
